EL
Elanco Animal Health
ELAN • United States
Drug Manufacturers - Specialty & Generic $11.41B 0.0 — -2.25%vs Kyowa Kirin Co.,Ltd.
4151 • Japan
Drug Manufacturers - Specialty & Generic $8.57B — — -3.21%vs 45
Eisai Co.,Ltd.
4523 • Japan
Drug Manufacturers - Specialty & Generic $7.83B — — -3.23%vs Shionogi & Co.,Ltd.
4507 • Japan
Drug Manufacturers - Specialty & Generic $16.68B — — -4.52%vs 68
Sichuan Biokin Pharmaceutical Co. Ltd. A
688506 • China
Drug Manufacturers - Specialty & Generic $18.00B 0.0 — -5.34%vs 45
Sumitomo Pharma Co.,Ltd.
4506 • Japan
Drug Manufacturers - Specialty & Generic $5.67B — — -9.26%vs IP
Drug Manufacturers - Specialty & Generic $15.73B 30.4 0.86% -1.97%vs Alkem Laboratories Limited
ALKEM • India
Drug Manufacturers - Specialty & Generic $7.17B 28.1 0.91% +2.27%vs Abbott India Limited
ABBOTINDIA • India
Drug Manufacturers - Specialty & Generic $5.92B 36.2 — -1.84%vs Shanghai Fosun Pharmaceutical Group Co Ltd
600196 • China
Drug Manufacturers - Specialty & Generic $10.24B 20.6 1.46% -4.01%vs ES
Eisai Co. Ltd
ESALF • United States
Drug Manufacturers - Specialty & Generic $8.67B 27.8 3.54% +0.00%vs Cipla Limited
CIPLA • India
Drug Manufacturers - Specialty & Generic $10.69B 21.9 — +0.16%vs Lupin Limited
LUPIN • India
Drug Manufacturers - Specialty & Generic $11.46B 22.9 — -0.67%vs RO
Laboratorios Farmaceuticos ROVI
ROVI • Spain
Drug Manufacturers - Specialty & Generic $5.14B 35.9 — +1.36%vs ES
Eisai Co. Ltd.
ESAIY • United States
Drug Manufacturers - Specialty & Generic $8.56B 26.8 3.57% -4.49%vs Aurobindo Pharma Limited
AUROPHARMA • India
Drug Manufacturers - Specialty & Generic $8.68B 22.9 — +0.38%vs 12
Hanmi Pharm Co Ltd
128940 • South Korea
Drug Manufacturers - Specialty & Generic $4.53B 0.0 0.39% -4.55%vs ZY
Zydus Lifesciences Limited
ZYDUSLIFE • India
Drug Manufacturers - Specialty & Generic $10.18B 19.1 — -1.12%vs MA
Mankind Pharma Ltd
MANKIND • India
Drug Manufacturers - Specialty & Generic $9.44B 49.2 — +4.54%vs IP
Ipsen S.A
IPSEF • United States
Drug Manufacturers - Specialty & Generic $9.32B 18.1 — +0.00%vs